Literature DB >> 15090795

Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania.

Willy Urassa1, Mohamed Bakari, Eric Sandström, Andrew Swai, Kisali Pallangyo, Ephraim Mbena, Fred Mhalu, Gunnel Biberfeld.   

Abstract

OBJECTIVE: To determine the rate of decline of CD4 T lymphocytes among HIV-1-infected individuals. DESIGN AND
SETTING: A prospective open cohort study of workers in three hotels in Dar es Salaam.
METHODS: The workers were seen yearly during the study. CD4 T lymphocyte counts were determined using flow cytometry. The CD4 T-lymphocyte slopes were determined using a linear regression model.
RESULTS: During the 9-year study period 682 subjects were selected for lymphocyte subset determinations. Of these, 94 HIV-1-seroprevalent (72%), 77 HIV-1-seroincident (67%) and 325 seronegative (75%) individuals had three or more CD4 T-cell determinations, and were used for calculations of CD4 cell slopes with a mean follow-up period of 71.4, 52.9 and 86.0 months, respectively. The median yearly decline of the CD4 T-lymphocyte counts and percentages among seroprevalent individuals was -21.5 cells/microl and -1.3%; among the seroincident individuals the median decline was -22.0 cells/microl and -1.5%. In seroincident individuals the mean duration to a CD4 T-lymphocyte level corresponding to a definition of AIDS was 13.3 years or 11.8 years for CD4 cell counts or percentages, respectively. HIV-1-seropositive subjects who died had significantly steeper CD4 cell slopes than those who survived.
CONCLUSION: The rates of CD4 T-lymphocyte decline in HIV-1-infected individuals in our population are similar to those reported in Europe and north America.

Entities:  

Mesh:

Year:  2004        PMID: 15090795     DOI: 10.1097/00002030-200402200-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  21 in total

Review 1.  The potential role for probiotic yogurt for people living with HIV/AIDS.

Authors:  Gregor Reid
Journal:  Gut Microbes       Date:  2010 Nov-Dec

2.  A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa.

Authors:  Richard C Waters; Jan Ostermann; Travis D Reeves; Max F Masnick; Nathan M Thielman; John A Bartlett; John A Crump
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

3.  HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.

Authors:  Noah Kiwanuka; Merlin Robb; Oliver Laeyendecker; Godfrey Kigozi; Fred Wabwire-Mangen; Fredrick E Makumbi; Fred Nalugoda; Joseph Kagaayi; Michael Eller; Leigh Anne Eller; David Serwadda; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Christopher C Whalen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

4.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

5.  Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy.

Authors:  Kjell Arne Johansson; Bjarne Robberstad; Ole Frithjof Norheim
Journal:  AIDS Res Ther       Date:  2010-01-16       Impact factor: 2.250

6.  CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland.

Authors:  Margaret May; Robin Wood; Landon Myer; Patrick Taffé; Andri Rauch; Manuel Battegay; Matthias Egger
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

7.  Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Authors:  Samuel O Pine; M Juliana McElrath; Pierre-Yves Bochud
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

8.  Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial.

Authors:  Paul Kelly; Max Katubulushi; Jim Todd; Rose Banda; Vera Yambayamba; Mildred Fwoloshi; Isaac Zulu; Emmanuel Kafwembe; Felistah Yavwa; Ian R Sanderson; Andrew Tomkins
Journal:  Am J Clin Nutr       Date:  2008-10       Impact factor: 7.045

9.  CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.

Authors:  Roger Ying; Reuben M Granich; Somya Gupta; Brian G Williams
Journal:  Clin Infect Dis       Date:  2016-01-29       Impact factor: 9.079

Review 10.  Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa.

Authors:  Eline L Korenromp; Brian G Williams; Sake J de Vlas; Eleanor Gouws; Charles F Gilks; Peter D Ghys; Bernard L Nahlen
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.